Global Demineralized Bone Matrix and Demineralized Allograft Market Growth 2026-2032

August 2026 | 104 pages | ID: G06004F8A756EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Demineralized Bone Matrix and Demineralized Allograft market size is predicted to grow from US$ 629 million in 2025 to US$ 998 million in 2032; it is expected to grow at a CAGR of 7.0% from 2026 to 2032.

Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.

The demineralized bone matrix market is primarily driven by the increasing demand for bone graft substitutes in orthopedic and dental surgeries. Demineralized bone matrix (DBM) is derived from human or animal bones and contains growth factors and proteins that promote bone regeneration and healing. The rising prevalence of musculoskeletal disorders, trauma, and dental conditions fuels the adoption of DBM as an effective and biocompatible bone graft material. However, the market also faces challenges, including the need for standardized and high-quality DBM products to ensure consistent clinical outcomes. Variability in DBM processing methods and composition may impact its efficacy and safety. Moreover, strict regulatory requirements and ethical concerns related to the sourcing and processing of DBM can pose challenges for manufacturers in the market.

LP Information, Inc. (LPI) ' newest research report, the “Demineralized Bone Matrix and Demineralized Allograft Industry Forecast” looks at past sales and reviews total world Demineralized Bone Matrix and Demineralized Allograft sales in 2025, providing a comprehensive analysis by region and market sector of projected Demineralized Bone Matrix and Demineralized Allograft sales for 2026 through 2032. With Demineralized Bone Matrix and Demineralized Allograft sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Demineralized Bone Matrix and Demineralized Allograft industry.

This Insight Report provides a comprehensive analysis of the global Demineralized Bone Matrix and Demineralized Allograft landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Demineralized Bone Matrix and Demineralized Allograft portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Demineralized Bone Matrix and Demineralized Allograft market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Demineralized Bone Matrix and Demineralized Allograft and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Demineralized Bone Matrix and Demineralized Allograft.

This report presents a comprehensive overview, market shares, and growth opportunities of Demineralized Bone Matrix and Demineralized Allograft market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Gel
  • Putty
  • Putty with Chips
  • Others
Segmentation by Application:
  • Dental Surgery
  • Spine Surgery
  • Trauma Surgery
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Medtronic
  • J &J (DePuy Synthes)
  • SeaSpine
  • Xtant Medical
  • Zimmer Biomet
  • Stryker
  • Straumann
  • Wright Medical Group
  • Hans Biomed
  • Arthrex
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global Demineralized Bone Matrix and Demineralized Allograft market?
  • What factors are driving Demineralized Bone Matrix and Demineralized Allograft market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Demineralized Bone Matrix and Demineralized Allograft market opportunities vary by end market size?
  • How does Demineralized Bone Matrix and Demineralized Allograft break out by Type, by Application?
1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
    2.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Annual Sales 2021-2032
    2.1.2 World Current & Future Analysis for Demineralized Bone Matrix and Demineralized Allograft by Geographic Region, 2021, 2025 & 2032
    2.1.3 World Current & Future Analysis for Demineralized Bone Matrix and Demineralized Allograft by Country/Region, 2021, 2025 & 2032
  2.2 Demineralized Bone Matrix and Demineralized Allograft Segment by Type
    2.2.1 Gel
    2.2.2 Putty
    2.2.3 Putty with Chips
    2.2.4 Others
    2.2.5 Demineralized Bone Matrix and Demineralized Allograft Sales by Type
      2.2.5.1 Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2021-2026)
      2.2.5.2 Global Demineralized Bone Matrix and Demineralized Allograft Revenue and Market Share by Type (2021-2026)
      2.2.5.3 Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Type (2021-2026)
  2.3 Demineralized Bone Matrix and Demineralized Allograft Segment by Application
    2.3.1 Dental Surgery
    2.3.2 Spine Surgery
    2.3.3 Trauma Surgery
    2.3.4 Demineralized Bone Matrix and Demineralized Allograft Sales by Application
      2.3.4.1 Global Demineralized Bone Matrix and Demineralized Allograft Sale Market Share by Application (2021-2026)
      2.3.4.2 Global Demineralized Bone Matrix and Demineralized Allograft Revenue and Market Share by Application (2021-2026)
      2.3.4.3 Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Demineralized Bone Matrix and Demineralized Allograft Breakdown Data by Company
    3.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Annual Sales by Company (2021-2026)
    3.1.2 Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Company (2021-2026)
  3.2 Global Demineralized Bone Matrix and Demineralized Allograft Annual Revenue by Company (2021-2026)
    3.2.1 Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Company (2021-2026)
    3.2.2 Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Company (2021-2026)
  3.3 Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Company
  3.4 Key Manufacturers Demineralized Bone Matrix and Demineralized Allograft Producing Area Distribution, Sales Area, Product Type
    3.4.1 Key Manufacturers Demineralized Bone Matrix and Demineralized Allograft Product Location Distribution
    3.4.2 Players Demineralized Bone Matrix and Demineralized Allograft Products Offered
  3.5 Market Concentration Rate Analysis
    3.5.1 Competition Landscape Analysis
    3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DEMINERALIZED BONE MATRIX AND DEMINERALIZED ALLOGRAFT BY GEOGRAPHIC REGION

  4.1 World Historic Demineralized Bone Matrix and Demineralized Allograft Market Size by Geographic Region (2021-2026)
    4.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Annual Sales by Geographic Region (2021-2026)
    4.1.2 Global Demineralized Bone Matrix and Demineralized Allograft Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Demineralized Bone Matrix and Demineralized Allograft Market Size by Country/Region (2021-2026)
    4.2.1 Global Demineralized Bone Matrix and Demineralized Allograft Annual Sales by Country/Region (2021-2026)
    4.2.2 Global Demineralized Bone Matrix and Demineralized Allograft Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Demineralized Bone Matrix and Demineralized Allograft Sales Growth
  4.4 APAC Demineralized Bone Matrix and Demineralized Allograft Sales Growth
  4.5 Europe Demineralized Bone Matrix and Demineralized Allograft Sales Growth
  4.6 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Growth

5 AMERICAS

  5.1 Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Country
    5.1.1 Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2021-2026)
    5.1.2 Americas Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2021-2026)
  5.2 Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2021-2026)
  5.3 Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Region
    6.1.1 APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Region (2021-2026)
    6.1.2 APAC Demineralized Bone Matrix and Demineralized Allograft Revenue by Region (2021-2026)
  6.2 APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2021-2026)
  6.3 APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Demineralized Bone Matrix and Demineralized Allograft by Country
    7.1.1 Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2021-2026)
    7.1.2 Europe Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2021-2026)
  7.2 Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2021-2026)
  7.3 Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft by Country
    8.1.1 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2021-2026)
    8.1.2 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2021-2026)
  8.2 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2021-2026)
  8.3 Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Demineralized Bone Matrix and Demineralized Allograft
  10.3 Manufacturing Process Analysis of Demineralized Bone Matrix and Demineralized Allograft
  10.4 Industry Chain Structure of Demineralized Bone Matrix and Demineralized Allograft

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
    11.1.1 Direct Channels
    11.1.2 Indirect Channels
  11.2 Demineralized Bone Matrix and Demineralized Allograft Distributors
  11.3 Demineralized Bone Matrix and Demineralized Allograft Customer

12 WORLD FORECAST REVIEW FOR DEMINERALIZED BONE MATRIX AND DEMINERALIZED ALLOGRAFT BY GEOGRAPHIC REGION

  12.1 Global Demineralized Bone Matrix and Demineralized Allograft Market Size Forecast by Region
    12.1.1 Global Demineralized Bone Matrix and Demineralized Allograft Forecast by Region (2027-2032)
    12.1.2 Global Demineralized Bone Matrix and Demineralized Allograft Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Demineralized Bone Matrix and Demineralized Allograft Forecast by Type (2027-2032)
  12.7 Global Demineralized Bone Matrix and Demineralized Allograft Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Medtronic
    13.1.1 Medtronic Company Information
    13.1.2 Medtronic Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
    13.1.3 Medtronic Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2021-2026)
    13.1.4 Medtronic Main Business Overview
    13.1.5 Medtronic Latest Developments
  13.2 J &J (DePuy Synthes)
    13.2.1 J &J (DePuy Synthes) Company Information
    13.2.2 J &J (DePuy Synthes) Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
    13.2.3 J &J (DePuy Synthes) Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2021-2026)
    13.2.4 J &J (DePuy Synthes) Main Business Overview
    13.2.5 J &J (DePuy Synthes) Latest Developments
  13.3 SeaSpine
    13.3.1 SeaSpine Company Information
    13.3.2 SeaSpine Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
    13.3.3 SeaSpine Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2021-2026)
    13.3.4 SeaSpine Main Business Overview
    13.3.5 SeaSpine Latest Developments
  13.4 Xtant Medical
    13.4.1 Xtant Medical Company Information
    13.4.2 Xtant Medical Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
    13.4.3 Xtant Medical Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2021-2026)
    13.4.4 Xtant Medical Main Business Overview
    13.4.5 Xtant Medical Latest Developments
  13.5 Zimmer Biomet
    13.5.1 Zimmer Biomet Company Information
    13.5.2 Zimmer Biomet Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
    13.5.3 Zimmer Biomet Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2021-2026)
    13.5.4 Zimmer Biomet Main Business Overview
    13.5.5 Zimmer Biomet Latest Developments
  13.6 Stryker
    13.6.1 Stryker Company Information
    13.6.2 Stryker Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
    13.6.3 Stryker Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2021-2026)
    13.6.4 Stryker Main Business Overview
    13.6.5 Stryker Latest Developments
  13.7 Straumann
    13.7.1 Straumann Company Information
    13.7.2 Straumann Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
    13.7.3 Straumann Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2021-2026)
    13.7.4 Straumann Main Business Overview
    13.7.5 Straumann Latest Developments
  13.8 Wright Medical Group
    13.8.1 Wright Medical Group Company Information
    13.8.2 Wright Medical Group Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
    13.8.3 Wright Medical Group Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2021-2026)
    13.8.4 Wright Medical Group Main Business Overview
    13.8.5 Wright Medical Group Latest Developments
  13.9 Hans Biomed
    13.9.1 Hans Biomed Company Information
    13.9.2 Hans Biomed Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
    13.9.3 Hans Biomed Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2021-2026)
    13.9.4 Hans Biomed Main Business Overview
    13.9.5 Hans Biomed Latest Developments
  13.10 Arthrex
    13.10.1 Arthrex Company Information
    13.10.2 Arthrex Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
    13.10.3 Arthrex Demineralized Bone Matrix and Demineralized Allograft Sales, Revenue, Price and Gross Margin (2021-2026)
    13.10.4 Arthrex Main Business Overview
    13.10.5 Arthrex Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Demineralized Bone Matrix and Demineralized Allograft Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Demineralized Bone Matrix and Demineralized Allograft Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Gel
Table 4. Major Players of Putty
Table 5. Major Players of Putty with Chips
Table 6. Major Players of Others
Table 7. Global Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2021-2026) & (K Units)
Table 8. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2021-2026)
Table 9. Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Type (2021-2026) & ($ million)
Table 10. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Type (2021-2026)
Table 11. Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Demineralized Bone Matrix and Demineralized Allograft Sale by Application (2021-2026) & (K Units)
Table 13. Global Demineralized Bone Matrix and Demineralized Allograft Sale Market Share by Application (2021-2026)
Table 14. Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Application (2021-2026) & ($ million)
Table 15. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Application (2021-2026)
Table 16. Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Demineralized Bone Matrix and Demineralized Allograft Sales by Company (2021-2026) & (K Units)
Table 18. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Company (2021-2026)
Table 19. Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Company (2021-2026)
Table 21. Global Demineralized Bone Matrix and Demineralized Allograft Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Demineralized Bone Matrix and Demineralized Allograft Producing Area Distribution and Sales Area
Table 23. Players Demineralized Bone Matrix and Demineralized Allograft Products Offered
Table 24. Demineralized Bone Matrix and Demineralized Allograft Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Demineralized Bone Matrix and Demineralized Allograft Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share Geographic Region (2021-2026)
Table 29. Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Demineralized Bone Matrix and Demineralized Allograft Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country/Region (2021-2026)
Table 33. Global Demineralized Bone Matrix and Demineralized Allograft Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2021-2026) & (K Units)
Table 36. Americas Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country (2021-2026)
Table 37. Americas Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2021-2026) & (K Units)
Table 39. Americas Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2021-2026) & (K Units)
Table 40. APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Region (2021-2026) & (K Units)
Table 41. APAC Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Region (2021-2026)
Table 42. APAC Demineralized Bone Matrix and Demineralized Allograft Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2021-2026) & (K Units)
Table 44. APAC Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2021-2026) & (K Units)
Table 45. Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2021-2026) & (K Units)
Table 46. Europe Demineralized Bone Matrix and Demineralized Allograft Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2021-2026) & (K Units)
Table 48. Europe Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Demineralized Bone Matrix and Demineralized Allograft
Table 54. Key Market Challenges & Risks of Demineralized Bone Matrix and Demineralized Allograft
Table 55. Key Industry Trends of Demineralized Bone Matrix and Demineralized Allograft
Table 56. Demineralized Bone Matrix and Demineralized Allograft Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Demineralized Bone Matrix and Demineralized Allograft Distributors List
Table 59. Demineralized Bone Matrix and Demineralized Allograft Customer List
Table 60. Global Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Demineralized Bone Matrix and Demineralized Allograft Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Demineralized Bone Matrix and Demineralized Allograft Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Demineralized Bone Matrix and Demineralized Allograft Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Demineralized Bone Matrix and Demineralized Allograft Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Medtronic Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 75. Medtronic Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 76. Medtronic Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Medtronic Main Business
Table 78. Medtronic Latest Developments
Table 79. J &J (DePuy Synthes) Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 80. J &J (DePuy Synthes) Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 81. J &J (DePuy Synthes) Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. J &J (DePuy Synthes) Main Business
Table 83. J &J (DePuy Synthes) Latest Developments
Table 84. SeaSpine Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 85. SeaSpine Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 86. SeaSpine Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. SeaSpine Main Business
Table 88. SeaSpine Latest Developments
Table 89. Xtant Medical Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 90. Xtant Medical Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 91. Xtant Medical Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Xtant Medical Main Business
Table 93. Xtant Medical Latest Developments
Table 94. Zimmer Biomet Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 95. Zimmer Biomet Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 96. Zimmer Biomet Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Zimmer Biomet Main Business
Table 98. Zimmer Biomet Latest Developments
Table 99. Stryker Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 100. Stryker Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 101. Stryker Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Stryker Main Business
Table 103. Stryker Latest Developments
Table 104. Straumann Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 105. Straumann Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 106. Straumann Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Straumann Main Business
Table 108. Straumann Latest Developments
Table 109. Wright Medical Group Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 110. Wright Medical Group Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 111. Wright Medical Group Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Wright Medical Group Main Business
Table 113. Wright Medical Group Latest Developments
Table 114. Hans Biomed Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 115. Hans Biomed Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 116. Hans Biomed Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Hans Biomed Main Business
Table 118. Hans Biomed Latest Developments
Table 119. Arthrex Basic Information, Demineralized Bone Matrix and Demineralized Allograft Manufacturing Base, Sales Area and Its Competitors
Table 120. Arthrex Demineralized Bone Matrix and Demineralized Allograft Product Portfolios and Specifications
Table 121. Arthrex Demineralized Bone Matrix and Demineralized Allograft Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Arthrex Main Business
Table 123. Arthrex Latest Developments

LIST OF FIGURES

Figure 1. Picture of Demineralized Bone Matrix and Demineralized Allograft
Figure 2. Demineralized Bone Matrix and Demineralized Allograft Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Demineralized Bone Matrix and Demineralized Allograft Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Demineralized Bone Matrix and Demineralized Allograft Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country/Region (2025)
Figure 10. Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Gel
Figure 12. Product Picture of Putty
Figure 13. Product Picture of Putty with Chips
Figure 14. Product Picture of Others
Figure 15. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type in 2026
Figure 16. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Type (2021-2026)
Figure 17. Demineralized Bone Matrix and Demineralized Allograft Consumed in Dental Surgery
Figure 18. Global Demineralized Bone Matrix and Demineralized Allograft Market: Dental Surgery (2021-2026) & (K Units)
Figure 19. Demineralized Bone Matrix and Demineralized Allograft Consumed in Spine Surgery
Figure 20. Global Demineralized Bone Matrix and Demineralized Allograft Market: Spine Surgery (2021-2026) & (K Units)
Figure 21. Demineralized Bone Matrix and Demineralized Allograft Consumed in Trauma Surgery
Figure 22. Global Demineralized Bone Matrix and Demineralized Allograft Market: Trauma Surgery (2021-2026) & (K Units)
Figure 23. Global Demineralized Bone Matrix and Demineralized Allograft Sale Market Share by Application (2025)
Figure 24. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Application in 2026
Figure 25. Demineralized Bone Matrix and Demineralized Allograft Sales by Company in 2026 (K Units)
Figure 26. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Company in 2026
Figure 27. Demineralized Bone Matrix and Demineralized Allograft Revenue by Company in 2026 ($ millions)
Figure 28. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Company in 2026
Figure 29. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Demineralized Bone Matrix and Demineralized Allograft Sales 2021-2026 (K Units)
Figure 32. Americas Demineralized Bone Matrix and Demineralized Allograft Revenue 2021-2026 ($ millions)
Figure 33. APAC Demineralized Bone Matrix and Demineralized Allograft Sales 2021-2026 (K Units)
Figure 34. APAC Demineralized Bone Matrix and Demineralized Allograft Revenue 2021-2026 ($ millions)
Figure 35. Europe Demineralized Bone Matrix and Demineralized Allograft Sales 2021-2026 (K Units)
Figure 36. Europe Demineralized Bone Matrix and Demineralized Allograft Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Revenue 2021-2026 ($ millions)
Figure 39. Americas Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country in 2026
Figure 40. Americas Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Country (2021-2026)
Figure 41. Americas Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2021-2026)
Figure 42. Americas Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Application (2021-2026)
Figure 43. United States Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Region in 2026
Figure 48. APAC Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Region (2021-2026)
Figure 49. APAC Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2021-2026)
Figure 50. APAC Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Application (2021-2026)
Figure 51. China Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 55. India Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country in 2026
Figure 59. Europe Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share by Country (2021-2026)
Figure 60. Europe Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2021-2026)
Figure 61. Europe Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Application (2021-2026)
Figure 62. Germany Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 63. France Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Demineralized Bone Matrix and Demineralized Allograft Sales Market Share by Application (2021-2026)
Figure 70. Egypt Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Demineralized Bone Matrix and Demineralized Allograft Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Demineralized Bone Matrix and Demineralized Allograft in 2026
Figure 76. Manufacturing Process Analysis of Demineralized Bone Matrix and Demineralized Allograft
Figure 77. Industry Chain Structure of Demineralized Bone Matrix and Demineralized Allograft
Figure 78. Channels of Distribution
Figure 79. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Forecast by Region (2027-2032)
Figure 80. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Demineralized Bone Matrix and Demineralized Allograft Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Demineralized Bone Matrix and Demineralized Allograft Revenue Market Share Forecast by Application (2027-2032)


More Publications